๐
Yondelis
trabectedin
Sarcoma
โ Refused
โ
No active alerts
This medicine has no ongoing shortages, safety letters or recalls.
What it's used for
Yondelis is indicated for the treatment of patients with advanced soft tissue sarcoma, having failed antracyclines and ifosfamide, or having failed ifosfamide and unsuitable to receive antracyclines/ifosfamide.
โ ๏ธ Patient safety
No
Official EMA page
https://www.ema.europa.eu/en/medicines/human/EPAR/yondelis-0